We have investigated the effects of propofol on beat-to-beat fluctuations in heart rate, arterial pressure (continuous arterial tonometry) 
Heart rate (HR) is controlled primarily by the interaction of parasympathetic and sympathetic inputs to the sinoatrial node. The balance of these autonomic inputs is regulated by the brain stem cardiovascular control centre in response to input from higher centres, baroreceptors, chemoreceptors and irradiation from the nearby respiratory centre. The periodic oscillations in HR caused by the interaction of these afferent inputs are complex but because some components have a specific frequency range, they may be separated using Fourier analysis [1] . Three component periodicities make up the typical HR time series [2] . Oscillations may be low frequency (approximately 0.05 Hz) caused by fluctuations in peripheral vasomotor activity, mid frequency (approximately 0.1 Hz) caused by a resonance phenomenon within the baroreflex loop or high frequency (0.15-0.5 Hz) occurring in phase with ventilation. In addition to HR variability (HRV), periodic fluctuations occur also in other cardiovascular variables and in particular arterial pressure (AP), indeed it is likely that low and mid frequency HRV is secondary to fluctuations in arterial pressure caused by phasic variation in peripheral alpha adrenergic tone [3] [4] [5] [6] [7] [8] . Inhalation [9] [10] [11] and i.v. [12] [13] [14] [15] anaesthetics, nitrous oxide [16] , opioids [17] , benzodiazepines [18] , artificial ventilation [19] and surgical stimulation [20] have significant effects on HRV [21] [22] [23] [24] . In general, with the onset of anaesthesia a marked reduction in variability in all frequency bands is observed, although the relative proportion of power in these bands may vary according to the effect of the anaesthetic on autonomic, respiratory and cardiovascular function. We have examined previously the effect of propofol total i.v. anaesthesia (TIVA) on spectral components of HRV [15] . As HR is only a single component of the complex cardiovascular control system, it may be of value to examine, using spectral analysis, the effect of anaesthesia on beat-tobeat variability of other cardiovascular variables. In this study, we have examined the effects of propofol on HR, AP and photoplethysmograph amplitude (PLA) variability. I male patients (mean age 27.8 yr, range 19-45 yr) undergoing elective surgery with TIVA using propofol. None was receiving regular medication or had evidence of respiratory or cardiovascular disease. Ten minutes before induction of anaesthesia, HR (ECG lead CM5, Corometrics Neo-Trak 502), AP (continuous non-invasive arterial tonometry, Nellcor N-CAT N-500), ventilation (impedance pneumograph, Corometrics Neo-Trak 502) and infrared finger plethysmograph (Hewlett-Packard 78330A, signal amplified in the band range 1-10 Hz) recording was commenced. The ECG signal was input to a purpose-built R wave detector that generated a 50-ms pulse synchronous with the peak of each R wave. This pulse triggered a Macintosh Ilex computer with a 16-bit ADC board (National Instruments) to record the R-R interval, the respiratory signal and to determine the following trough (diastole) and peak (systole) of each subsequent photoplethysmograph and arterial pressure wave.
Anaesthesia was induced with propofol (Diprivan) 0.2 ml kg" 1 over 30 s and maintained with an infusion of propofol 1 ml kg" 1 h~' with spontaneous breathing of 100% oxygen. Arterial oxygen saturation (Sp O; ) was monitored (Datex Satlite Trans) and maintained greater than 95 % with gentle IPPV if required. Recording of cardiorespiratory data continued for 10 min after induction.
Fast Fourier analysis on 256-s epochs of HR, respiration, systolic AP (SAP), diastolic AP (DAP) and PLA was performed using methods described previously [15, 25] . Epochs were taken from the 5 min before and from the 5-10 min after induction of anaesthesia. Spectral power (area under the power spectrum curve) was calculated for each variable and the proportion of spectral power in three frequency ranges was calculated: low frequency ("vasomotor", 0.02-0.08 Hz), mid frequency ("baroreflex", 0.08-0.15 Hz) and high frequency ("ventilatory", 0.15-0.45 Hz).
Mean (SD) changes in total spectral power and the three spectral frequency components were analysed using paired non-parametric analysis (Wilcoxon signed-rank).
Differences were considered significant at P < 0.05. Table I compares the values for each time and frequency domain variable and table II summarizes the main cardiovascular changes over the period of induction. Figure 1A and B shows the beat-to-beat fluctuations during the induction period in two representative patients and figure 2 summarizes the main spectral changes observed in this study. No patient required ventilation during the induction period and all inductions were smooth and free from purposeful movement.
RESULTS

Heart rate
There was acceleration of HR (from a baseline mean of 68 beat min" 1 ) which commenced, on average, 25 s after the start of injection of propofol. HR reached a mean peak of 95 beat min" 1 at 47 s after the start of injection of propofol and returned towards preanaesthetic rates, with a plateau by approximately 84 s. Tachycardia occurred approximately 5 s before the onset of hypotension. During the subsequent infusion there was no change in mean HR compared with control and a small nonsignificant decrease in the SD of individual R-R intervals. Spectral analysis of HRV indicated significant reductions in absolute total, mid and high frequency powers and the proportion of power in the mid and high frequency bands. There was a significant increase in the percentage of power in the low frequency band and a decrease in the proportion of mid frequency power.
Arterial pressure
Approximately 30 s after the start of injection of propofol, SAP and DAP decreased, followed by a reduction in pulse pressure at 34 s. SAP decreased from a mean of 135 to 97 mm Hg by 60 s after the start of injection of propofol. AP was sustained at slightly greater levels during the subsequent infusion period. Significant reductions in variability (i.e. SD) of SAP and DAP occurred and spectral analysis of SAP time series indicated significant reductions in total power and absolute and percentage powers in the low and mid frequency ranges. Spectral analysis of DAP indicated significant reductions in total power, absolute power in the mid and low frequency ranges and the proportion of power in the low frequency range. There was a significant increase in absolute power and percentage power of SAP in the high frequency range. DAP also showed an increase in percentage power in the high frequency range.
Photoplethysmograph
All subjects showed a markedly increased PLA after induction with propofol. In five subjects these 
Respiration
After induction of anaesthesia, there was a significantly increased respiratory frequency with decreased pneumogram amplitude of variable duration. DISCUSSION We have examined the effect of propofol on beat-tobeat variability in HR, AP and the photoplethysmogram waveform. Both HR and photoplethysmogram were measured using standard monitoring devices, while AP was measured noninvasively using an N-CAT N-500 radial artery tonometer. Arterial tonometry has been used previously for power spectral analysis of fluctuations in AP [26] . The device comprises a series of small piezoresistive pressure transducers applied over the radial artery with sufficient pressure in order to flatten the artery slightly. The transducer sensing the largest arterial waveform is used for measurement and this waveform is calibrated against an oscillometric AP recording to derive AP. Arterial tonometry follows rapid changes in AP closely although measurements may drift after each recalibration [27] . The spectral power of rapid fluctuations in AP (e.g. > 0.02 Hz) is probably accurate, although the absolute values given for AP and the power of low frequency fluctuations may be influenced by drift. For this reason we recalibrated the N-CAT at 5-min intervals, between those epochs used for spectral analysis.
A consistent feature of induction of anaesthesia with propofol is the transient increase in HR which occurs during or soon after injection [10, 28] . Tachycardia persists for approximately 1 min and then remains steady at a value little different from control values. A secondary baroreflex response to hypotension is an unlikely explanation for the increase in HR as in the majority of subjects its onset precedes the decrease in AP by approximately 5 s. The rapid onset of tachycardia suggests a direct cardiac cause or one mediated via the central nervous system. Although we have suggested previously that an arousal response to the perception of initial drug effect could explain the increase in HR, in no patient did we observe decreased PLA or an increase in SAP that might be expected to accompany such a response. The concomitant reduction in (vagally mediated) high frequency HRV suggests that vagolysis was the causative mechanism. Apart from the initial tachycardia, some studies have observed a general increase in HR during propofol anaesthesia [14, 28, 29] while the majority have found no increase, or even a decrease after a bolus [30] or infusion [31] [32] [33] [34] [35] . As the initial tachycardia subsided, AP was maintained at 25-30% less than preinduction values, consistent with a rapid resetting of the baroreflex set point [28, 31, 32] .
Two components of the plethysmograph signal have been described [36] . Phasic fluctuations in conjunction with each heart beat (PLA) are related to the product of pulse pressure and vascular distensibility, the latter being affected predominantly by peripheral alpha adrenergic tone. The slow baseline fluctuations in phase with ventilation are said to be related to changes in digital blood volume, primarily in venous beds [36] , although at least one study showed a clear relationship with digital blood flow [37] . After induction, PLA increased markedly, and is consistent with peripheral sympatholysis [38, 39] . In some subjects a transient decrease in PLA occurred during the initial reduction in AP. This was probably secondary to a decrease in pulse pressure although a transient increase in peripheral sympathetic tone cannot be ruled out. As pulse pressure declined, on average, 10 s before any increase in PLA, it is likely that reduced central alpha adrenergic activity to cutaneous vessels does not mediate the initial hypotension, although this may be relevant in sustaining the hypotension. In addition, Krassioukov, Weaver and Gelb observed that renal sympathetic discharges decreased after propofol, although this decrease followed the onset of hypotension [40] . We suggest that mechanisms for the onset of hypotension might include (a) myocardial depression, (b) pulmonary vascular dilatation causing central pooling and a transient reduction in left ventricular preload, or (c) decrease in total peripheral vascular resistance caused by vasodilatation in vascular beds other than that examined by digital plethysmography.
The different temporal sequences of cardiovascular alterations suggest separate mechanisms for HR, AP and plethysmograph changes during the immediate postinduction period. Tachycardia appears to be unrelated to the reduction in AP which appears to be unrelated to changes in cutaneous adrenergic tone. Over the first few minutes the dominant mechanism of hypotension may depend on the time of measurement; the initial mechanism during induction may be cardiac in origin while subsequent reductions in central adrenergic tone, or direct vascular effects, maintain the lowered pressure. The multifactorial genesis of hypotension after propofol is supported by the many studies that have demonstrated significant effects on preload or capacitance [33, 41, 42] , vascular resistance [30, 34, 42] and myocardial contractility [35] .
The effects of propofol on the spectral components of beat-to-beat cardiovascular variability differ according to the physiological variable. In general, changes in AP variability were similar to those of the photoplethysmogram with a marked reduction in low and mid frequency components and a shift towards high frequency dominance. In contrast, HRV showed reductions in mid and high frequency power with little alteration in the low frequency band. Consequently, the dominant power shifted to the high frequency band for both plethysmograph and AP while HR tended towards the low frequency band. These effects of propofol on HRV [15] and SAP [43] are similar to those described previously.
Several mechanisms have been postulated for the genesis of high frequency HRV in phase with ventilation, although it is likely that the dominant mechanism varies according to circumstance. "Ventilatory" HRV waves (equivalent to the Traube-Herring pressure waves) occur in paralysed and unventilated animals, suggesting that these fluctuations are caused by central irradiation of the cardiovascular control mechanism by the respiratory centre [5] . Conversely, HR fluctuations occur in the presence of a denervated transplanted heart, suggesting that under these circumstances mechanical or intrathoracic pressure changes may alter HR, perhaps through an intrinsic action on atrial or sinoatrial stretch [44, 45] . A third postulated mechanism is that high frequency HR fluctuations are secondary to AP fluctuations that occur as a result of changes in intrathoracic pressure and affect HR through baroreflex mechanisms [43, 46] . It can be shown by cross correlation however, that ventilatory HRV is in phase with AP variability and not lagging, as might be expected with a secondary HR baroreflex response [47] . Also, in dogs with a fixed HR by pacing, the high frequency AP component decreases by two orders of magnitude [48] . Thus ventilatory AP fluctuations are secondary to ventilatory HRV and not vice versa. High frequency fluctuations in HRV are mediated by the vagus and are blocked by atropine.
During infusion of propofol, high frequency HRV diminished while SAP and PLA high frequency power increased. Although it is possible that reduced high frequency HRV was caused by a central vagolytic mechanism, it is likely that diminished respiratory depth or effort, as shown by the reduction in pneumogram amplitude, would play a part in this effect [43] . In contrast with the increase in SAP variability, the high frequency DAP variability decreased, presumably because DAP is affected by the RR interval (the variability of which decreased) and the period of peripheral blood flow. The increase in high frequency spectral power in both SAP and plethysmograph is a reflection of the well described enhancement of respiratory waves seen in these measures during anaesthesia. These are more noticeable during intermittent positive pressure ventilation [36] and may be used as an index of the degree of hypovolaemia or pulmonary capillary wedge pressure [49, 50] . High frequency fluctuations in AP are thought to be secondary to HRV and to a lesser extent to the mechanical or intrathoracic fluctuations in pressure [4, 51] . High frequency fluctuations in PLA may be affected by changes in blood flow or venous back pressure from the fluctuations in intrathoracic pressure. An increase in venous capacitance, which has been demonstrated for propofol [33, 41, 42] , could be expected to exaggerate the effect of intrathoracic pressure changes on venous return, thereby affecting stroke volume (and hence AP and PLA variability), especially in the absence of any compensatory fluctuations in HR. We postulate that, during the control condition, high frequency AP is caused by predominantly high frequency HRV, whereas during propofol anaesthesia, high frequency HRV is diminished (perhaps by ventilatory depression) and the dominant high frequency fluctuations in AP become secondary to changes in intrathoracic pressure. It is unlikely that phasic fluctuations in peripheral adrenergic tone could influence AP at this ventilatory frequency as the frequency response of die vascular system is sluggish and the vasculature cannot respond at such high frequencies, acting instead as a form of integrator [52] (see [5] for a dissenting opinion, however).
Mid band frequency (approximately 0.1 Hz) fluctuations in HR are believed to reflect a resonance phenomenon within the high pressure baroreflex loop and are related to the 10-s fluctuations that occur in AP (Mayer waves). Unlike high frequency ventilatory fluctuations, where HR and AP occur in phase, the 0.1-Hz HR fluctuation lags after the 0.1 -Hz Mayer wave activity of AP [47] . Thus the HR response is probably, in part, secondary to the fluctuations in AP. Some authors believe that the fluctuation in AP is related to the output of a 10-s (0.1 Hz) central oscillator that drives corresponding fluctuations in peripheral alpha adrenergic tone [5, 53] , although it is also possible that spontaneous oscillations in central adrenergic outflow could occur in a control system that incorporates a baroreflex feedback loop with delay [54] . Lower frequency HRV fluctuations, which occur at approximately 0.05 Hz, are thought to represent thermoregulatory activity or vasomotor regulation of tissue blood flow. Both low and mid frequency fluctuations in AP are mediated by central sympathetic alpha adrenergic outflow [26, 55] and are increased by conditions that demand a sympathetic response, such as standing [56] and hypovolaemia [57] [58] [59] . The marked reduction in these components produced by propofol most likely represents the known diminution of peripheral sympathetic outflow [28, 38] . The 0.1-Hz oscillations in HR, AP and plethysmograph are reduced markedly during anaesthesia, perhaps representing a disruption occurring within the baroreflex mechanism (altering the baroreflex loop from one that optimally resonates) or a direct depression of the central 0.1-Hz oscillator.
Low frequency 0.05-Hz HRV seems to be less affected during infusion of propofol in contrast with mid and high frequency power. As the low frequency fluctuations are believed to involve a peripheral adrenergic mechanism and as PLA and SAP variability in this band are both reduced markedly, the relative preservation of low band HRV may be simply a reflection of the more marked decreases in mid band and high band power because of a combination of baroreflex impairment, decreased ventilation and possibly vagal withdrawal. Although Kato and colleagues observed a general depression of low frequency components during isoflurane-nitrous oxide anaesthesia, they also noted that at concentrations of isoflurane associated with burst suppression, transient increases in low frequency oscillatory activity occurred with HR elevations during bursts and falls during each suppression [9] . Maintained or enhanced low frequency activity could therefore also be associated with the direct effects of anaesthesia on the brain rather than on the heart or peripheral vasculature.
In summary, measurement of beat-to-beat alterations in non-invasive cardiovascular indices provides information on the cardiovascular effects of propofol that may not be apparent when averaged recordings are made. These results suggest that propofol causes hypotension by a sequence of mechanisms and has a complex action on beat-tobeat variability consistent with its known effects on baroreflex resetting, sympatholysis and increased venous capacitance.
